RETSX
Price
$105.02
Change
-$0.59 (-0.56%)
Updated
Jul 13 closing price
Net Assets
12.65B
VSMPX
Price
$337.67
Change
-$2.70 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

RETSX vs VSMPX

RETSX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
RETSX vs. VSMPX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RETSX is a Buy and VSMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.3T vs. RETSX (12.6B). VSMPX pays higher dividends than RETSX: VSMPX (1.06) vs RETSX (0.41). RETSX was incepted earlier than VSMPX: RETSX (30 years) vs VSMPX (11 years). RETSX (0.90) is less costly to investors than VSMPX (0.02). RETSX is a more actively managed with annual turnover of: 31.00 vs. VSMPX (3.00). RETSX has a lower initial minimum investment than VSMPX: RETSX (0) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 21.48 vs. RETSX (18.46). VSMPX return over 5 years is better than : 66.52 vs. RETSX (63.23).
RETSXVSMPXRETSX / VSMPX
Total Expense Ratio0.900.024,500%
Annual Report Gross Expense Ratio0.900.024,500%
Fund Existence30 years11 years-
Gain YTD9.72511.20687%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.6B2.3T1%
Annual Yield % from dividends0.411.0638%
Returns for 1 year18.4621.4886%
Returns for 3 years61.6867.0392%
Returns for 5 years63.2366.5295%
Returns for 10 years225.72239.4394%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGSNX21.35N/A
N/A
Vanguard Real Estate Index Institutional
PCAOX91.03N/A
N/A
Principal Capital Appreciation R3
GARIX23.88N/A
N/A
Gotham Absolute Return Institutional
RLAIX24.27N/A
N/A
T. Rowe Price Latin America I
MCYCX15.72-0.49
-3.02%
NYLI Candriam Emerging Markets Eq Cl C